Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RVL Pharmaceuticals plc | EVP, Research & Development | Ordinary Shares | 136K | $4.25K | $0.03 | May 18, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVLP | RVL Pharmaceuticals plc | May 18, 2022 | 1 | -$7.63K | 4 | May 20, 2022 | EVP, Research & Development |
RVLP | RVL Pharmaceuticals plc | Jan 24, 2022 | 1 | -$10.9K | 4 | Jan 26, 2022 | EVP, Research & Development |
RVLP | Osmotica Pharmaceuticals plc | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | EVP, Research & Development |
RVLP | Osmotica Pharmaceuticals plc | May 18, 2021 | 1 | -$20.2K | 4 | May 20, 2021 | EVP, Research & Development |